Ophthalmology 98(5 Suppl):80722 Ossoinig KC (1975) A-scan echography and orbital disease
Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China
Concomitantly, autophagy was reported to also reduce the hepatocyte apoptosis caused by steatosis and endoplasmic reticulum stress, possibly through the GLP-1RA-stimulated GLP-1R-mediated activation of the EB transcription factor of the autophagy-lysosome pathway, thus reducing the accumulation of liver lipids (201)
Summary of Key Takeaways Managing a thyroid condition while taking a GLP-1 is entirely possible, but it requires a proactive and cautious approach
Journal Diabetes Investigation, 11 ,
Safety Considerations and Adverse Effects While GLP-1 receptor agonists offer numerous benefits, clinicians should be mindful of potential adverse effects